<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 2054
Form 12b-25
NOTIFICATION OF LATE FILING
X Form 10-K Form 20-F Form 11-K Form 10-Q Form N-SAR
- --- --- --- --- ---
Commission file number 0-27727
--------
GENE CELL, INC.
------------------------
Full Name of Registrant
N/A
-------------------
Former Name of Registrant
1010 HERCULES
------------------
Address of Principal Executive Offices (Street and Number)
HOUSTON, TEXAS 77058
------------------------
City, State and Zip Code
PART II - RULES 12b-25 (b) AND (c)
If the subject could be filed without unreasonable effort or expense and
the Registrant seeks relief pursuant to Rule 12b-25 (b), the following
should be completed. (Check if appropriate).
(a) The reasons described in reasonable detail in Part III of this
form could not eliminated without unreasonable effort of expense;
X (b) The subject annual report, semi-annual report, transition report
- ---- on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or portion
thereof, will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
X (c) The accountant's statements or other exhibit required by Rule
- ---- 12b-25 (c) has been attached if applicable.
</Page>
<PAGE>
PART III - NARRATIVE
--------------------
The Company was delayed in compiling certain financial information
necessary for it to complete its audit for the year ended December 31,
1999. The Company expects to complete the financial statements and file
its annual report on Form 10 KSB on or before April 14, 2000.
The Company has filed all other reports required since reporting
requirements were instituted.
There are not any significant changes anticipated in the results of
operations from the corresponding period of the last fiscal year that will
be reflected by the earnings statements to be included in the subject
report or portion thereof.
PART IV - OTHER INFORMATION
- ---------------------------
Name and telephone number of person to contact in regard to this
notification.
Brian R Davis (281) 461-7996
- ---------------- ----------- ------------------
(Name) (Area Code) (Telephone Number)
The Company has filed all other reports required since reporting
requirements were instituted.
There are not any significant changes anticipated in the results of
operations from the corresponding period the last fiscal year that will be
reflected by the earnings statements to be included in the subject report
or portion thereof.
</Page>
<PAGE>
GENE CELL, INC., has caused this notification to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: March 30, 2000 By:/S/ Brian R. Davis
-----------------------------
Brian R. Davis, President
</Page>
